Summary by Moomoo AI
Qiming Medical-B held the first extraordinary general meeting of shareholders, H-share category shareholders meeting, and non-listed foreign shareholders meeting in China Hangzhou on October 10, 2024. Except for the 2nd and 6th resolutions that were not passed, all other resolutions were formally approved by the shareholders. Ms. Li Xiaojuan was elected as a director, and the company's articles of association, shareholder meeting rules, board meeting rules, and supervisory board meeting rules were amended. In addition, the board of directors obtained a general authorization to repurchase H-share shares. The meeting was chaired by Mr. Hu Dingxu, the board chairman, and all voting results were in compliance with relevant Chinese laws and regulations and the company's articles of association, legally valid. Executive Directors Mr. Lin Haosheng, Mr. Ma Liqiao, and Ms. Liu Meirong, Non-Executive Directors Mr. Zhang Ao and Mr. Wang Wei, and Independent Non-Executive Directors Mr. Hu Dingxu and Mr. Sun Zhiwei all attended the meeting.
